Hartford Investment Management CO Myriad Genetics Inc Transaction History

Hartford Investment Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 29, 2019	SELL	$26.93 - $34.7 $318,528 - $410,431	-11,828 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$27.23 - $45.56 $133,427 - $223,244	4,900 Added 70.73%	11,828 $344,000
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $17,357 - $23,257	-462 Reduced 6.25%	6,928 $319,000
Q2 2018 Jul 19, 2018	BUY	$27.75 - $40.17 $205,072 - $296,856	7,390 New	7,390 $276,000
Q4 2017 Feb 12, 2018	SELL	$28.45 - $37.14 $261,455 - $341,316	-9,190 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $220,651 - $332,678	9,190	9,190 $332,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Hartford Investment Management CO with notifications on news.